NCT06253858 Ultrasound (US) Guided External Ventricular Catheter Placement
| NCT ID | NCT06253858 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Milton S. Hershey Medical Center |
| Condition | Hydrocephalus |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2026-04-01 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To assess the accuracy the SOLOPASS® System US based in the placement of external ventricular drain into the cranial cavity. This study will aim at evaluating the proposed efficacy of the device in targeting the brain ventricles and decrease multiple brain passes, incorrect deployment and malfunctioning of the drain.
Eligibility Criteria
Inclusion Criteria: * Decision made to perform the procedure by the primary consultant * Age 18 or older * Neuro ICU stay * Newly diagnosed hydrocephalus * Has a recent CT within the past 24 hrs * Normal platelets and coagulation profile * No active infection or currently on antibiotics * The targeted fluid compartment has more than 50 percent CSF vs blood by CT scan imaging Exclusion Criteria: * Age \<18 * Not in Neuro ICU setting * Previous placement of a ventricular catheter * More than 50 percent of the fluid compartment is filled with blood by CT scan * Time to include in the trial prohibited by clinical personnel
Contact & Investigator
J C Zacko, MD
PRINCIPAL INVESTIGATOR
Milton S. Hershey Medical Center
Frequently Asked Questions
Who can join the NCT06253858 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hydrocephalus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06253858 currently recruiting?
Yes, NCT06253858 is actively recruiting participants. Contact the research team at scraig2@pennstatehealth.psu.edu for enrollment information.
Where is the NCT06253858 trial being conducted?
This trial is being conducted at Hershey, United States.
Who is sponsoring the NCT06253858 clinical trial?
NCT06253858 is sponsored by Milton S. Hershey Medical Center. The principal investigator is J C Zacko, MD at Milton S. Hershey Medical Center. The trial plans to enroll 10 participants.